What happened
HLB Therapeutics updated a previously disclosed supply contract with the Public Procurement Service, now worth US$2.78M, about 6.91% of its recent annual revenue, running through Aug 2026.
For context, this single contract equals about 6.91% of the company's most recent annual revenue.
| Counterparty | the Public Procurement Service |
|---|---|
| Contract value | US$2.78M |
| vs. recent revenue | 6.91% |
| Through | Aug 2026 (from Nov 2025) |
| Filed | 2026-08-31, [Amended] Supply contract signed |
| Source | DART rcept 20260831900731 → open original filing |
Source: DART. Information only, not investment advice.